WASHINGTON, D.C.: Pfizer received full approval on Thursday for its Covid-19 pill paxlovid that has been the go-to treatment against the coronavirus.

More than 11 million prescriptions for paxlovid have been dispensed since the Food and Drug Administration (FDA) allowed emergency use in late 2021. The emergency status was based on early studies and was intended to be temporary pending follow-up research.

Premium + Digital Edition

Ad-free access

P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

See details
See details